GRD Biotechnology Acquisition Limited (CGRD)
GRD Biotechnology Acquisition will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
4,000,000
Deal Size
$40.00M
Company Description
GRD Biotechnology Acquisition Limited is a newly incorporated blank check company, incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
We intend to focus our search in the Asian biotechnology sector.
GRD Biotechnology Acquisition Limited
| Country | China |
| Founded | 2023 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Zhonghua Gao |
Contact Details
Address: International Biomedical Technology Incubation Park A1-2, No. 66 Nanhu Road Deyang, Sichuan China | |
| Phone | (+86) 13811291184 |
Stock Details
| Ticker Symbol | CGRD |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001986500 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Zhonghua Gao | Chief Executive Officer and Chairman |
| Meimei Xiao | Chief Financial Officer and Director |
| Xiaoning Nie | Director Nominee |
| Xue Zhang | Director Nominee |
| Junjie Cheng | Director Nominee |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 26, 2023 | S-1 | General form for registration of securities under the Securities Act of 1933 |